Abiopharma

Clinical trial NCT06045988 updates: 1. start date: 2026-02-01 → 2026-07-01 2. completion date: 2026-08-01 → 2026-12-01 3. primary completion date: 2026-08-01 → 2026-12-01

Clinical trial NCT06631677: status: TEMPORARILY_NOT_AVAILABLE → AVAILABLE.

Clinical trial NCT06107738 updates: 1. completion date: 2026-12-31 → 2028-12-31 2. primary completion date: 2025-12-31 → 2027-12-31

Clinical trial NCT07158905 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-03 → 2026-06-23

Clinical trial NCT07262567 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2025-12-04

Clinical trial NCT07471841 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-07-01

Clinical trial NCT07527910 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-20 → 2026-05-22 3. completion date: 2029-11-27 → 2030-03-15 4. primary completion date: 2029-11-27 → 2030-03-15

Clinical trial NCT05082285: enrollment: 724 → 726 participants.

Clinical trial NCT06236139: collaborators added: National Cancer Institute (NCI).

Clinical trial NCT06444113: primary completion date: 2026-05-18 → 2026-02-20.